A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma

Background and Importance. In the last eight years temozolomide (TMZ) has been used as the last-line treatment modality for aggressive pituitary tumors to be applied after the failure of surgery, medical therapy, and radiotherapy. The objective was to achieve a rapid control of tumor growth and horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Misir Krpan, Ana, Dusek, Tina, Rakusic, Zoran, Solak, Mirsala, Kraljevic, Ivana, Bisof, Vesna, Ozretic, David, Kastelan, Darko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357528/
https://www.ncbi.nlm.nih.gov/pubmed/28357143
http://dx.doi.org/10.1155/2017/2419590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357528/
https://www.ncbi.nlm.nih.gov/pubmed/28357143
http://dx.doi.org/10.1155/2017/2419590

Ejemplares similares